Isomorphic Labs
Alphabet spinout led by Demis Hassabis using AI to design new drugs.
isomorphiclabs.com ↗Why it's here
Raised a $2.1B Series B led by Thrive Capital in May 2026, a year after its first $600M external round.
source: isomorphiclabs.com- Focus
- AI drug discovery
- Founded
- 2021
- Total raised
- $2.7Bsource: isomorphiclabs.com
- Latest round
- Series B, $2.1B, May 2026
- London office
- 22 Handyside Street, King's Cross, London, Camden N1C 4DNsource: app.welcometothejungle.com
- London presence
- HQsource: en.wikipedia.org
- Investors
- Thrive Capital (lead), Alphabet, CapitalG, GV, MGX, Temasek, UK Sovereign AI Fundsource: isomorphiclabs.com
- Area
- King's Cross
- Nearest station
- King's Cross & St Pancras International, 638 m
- Hiring
- 15 open roles in London ↗Public job board, checked 9 Oct 2026
- Visas
- Licensed visa sponsor, listed as Isomorphic Labs Limitedsource: gov.uk
Verified 30 Sep 2026. How we verify · Suggest a fix